BC
CLRB icon

Boxer Capital’s Cellectar Biosciences CLRB Stock Holding History

Boxer Capital’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,067
Closed -$851K – 74
2021
Q3 		$851K Hold
3,067
– – 0.03% 86
2021
Q2 		$1.09M Hold
3,067
– – 0.04% 92
2021
Q1 		$1.48M Hold
3,067
– – 0.05% 83
2020
Q4 		$1.91M Hold
3,067
– – 0.06% 76
2020
Q3 		$1.14M Hold
3,067
– – 0.04% 74
2020
Q2 		$1.18M Hold
3,067
– – 0.05% 64
2020
Q1 		$1.23M Hold
3,067
– – 0.08% 60
2019
Q4 		$2.07M Hold
3,067
– – 0.12% 51
2019
Q3 		$1.84M Hold
3,067
– – 0.13% 47
2019
Q2 		$2.01M Buy
+3,067
New +$2.09M 0.18% 36

Other funds holding CLRB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $1.73B AUM 44.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return